[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Elanco: Performance, Capabilities, Goals and Strategies in the Worldwide Animal Health Market

January 2010 | 25 pages | ID: E89B74D46E5EN
Venture Planning Group

US$ 1,480.00 US$ 1,850.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global PDF: US$ 3,900.00

A strategic assessment of Elanco/Eli Lilly, one of the world’s leading animal health companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company’s performance, capabilities, goals and strategies in the global animal health market.

Contains 25 pages and 3 tables
I. BUSINESS ORGANIZATION

II. SENIOR MANAGEMENT

III. FACILITIES AND EMPLOYEES

IV. TECHNOLOGICAL KNOW-HOW

V. PRODUCT PORTFOLIO

VI. MARKETING TACTICS

VII. SALES AND PROFIT GROWTH

VIII. R&D EXPENDITURES AND MAJOR PROGRAMS

IX. COLLABORATIVE ARRANGEMENTS

X. STRATEGIC DIRECTION

LIST OF TABLES


Table 1: Eli Lilly/Elanco Sales by Business Segment
Table 2: Eli Lilly/Elanco Sales Growth by Business Segment
Table 3: Eli Lilly/Elanco Animal Health Sales By Geographic Region


More Publications